Showing results (431-440 of 653) with videos related to

Sort By:
Pageof 66
Frontiers in Nutrition|February 27, 2023
Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover studyHelena Zander Wodschow, Filip Søskov Davidovski, Jacob Christensen, et al.
Kidney International|November 11, 2022
A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetesGeorge L Bakris, Luis M Ruilope, Stefan D Anker, et al.
Diabetes Care|May 25, 2019
Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 DiabetesSigne A Winther, Jens C Øllgaard, Nete Tofte, et al.
Diabetes|January 21, 2022
Randomized Controlled Trial of the Hemodynamic Effects of Empagliflozin in Patients With Type 2 Diabetes at High Cardiovascular Risk: The SIMPLE TrialEmil Wolsk, Mikkel Jürgens, Morten Schou, et al.
Clinical Kidney Journal|February 24, 2023
Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetesJens Christian Laursen, Niels Søndergaard-Heinrich, Bryan Haddock, et al.
BMJ Open|March 20, 2024
Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trialsShweta Bansal, Maria E F Canziani, Rita Birne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 11, 2016
Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 studyMorten Lindhardt, Frederik Persson, Petra Zürbig, et al.
Journal of Hypertension|December 30, 2022
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetesRajiv Agarwal, Luis M Ruilope, Gema Ruiz-Hurtado, et al.
Frontiers in Clinical Diabetes and Healthcare|March 30, 2023
Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled TrialAsger Wretlind, Emilie Hein Zobel, Andressa de Zawadzki, et al.
Kidney International|July 16, 2017
Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies ConferenceColin Baigent, William G Herrington, Josef Coresh, et al.
Pageof 66